Newsletter subscription & archive

Deep Dive - outsourcing R&D for Advanced Therapies – Flow Cytometry - webinar

This event sets out to provide insight to industry on practical applications from two immunology CROs on offering standardized and custom-tailored flow cytometry solutions. A high-level view of the scientific approach and the regulatory aspect will be presented and discussed

When

07-07-2020 15:00 - 16:30

Organizer

Covance, ImmuMap, Biopeople

Outsourcing R&D for Advanced Therapies – Flow Cytometry

Ever increasing proportions of research & development activities are conducted by contract-research-organizations (CROs) on behalf of biotech and pharma companies. However, how is subcontracted flow cytometry managed for Advanced Therapy Medicinal Products (ATMPs). This event sets out to provide insight to industry on practical applications from two immunology CROs on offering standardized and custom-tailored flow cytometry solutions. A high-level view of the scientific approach and the regulatory aspect will be presented and discussed.

Programme

15:00: Check-in and Welcome, Per Spindler, Biopeople, Denmark

15:10-15:35: CRO support for pre-clinical and clinical Biopharmaceutical development. Meeting regulatory requirements through an understanding of immune responses by flow cytometry. Chris Rothwell, Covance, United Kingdom

15:35-15:50: Contract flow cytometry for pre-clinical and clinical exploratory endpoints to assess mode-of-action and immunotoxicology. Houman Pourhassan, ImmuMap, Denmark

15:50-16:30: The chat will be open and the presenters will answer questions and discuss as appropriate.

Would you like to participate in the event?

You are welcome! It is free of charge, but registration is mandatory here. Webinar log-in information will be sent to you following your registration.

For further information, please contact:

Per Spindler, Biopeople, pesp@biopeople.ku.dk

Houman Pourhassan, ImmuMap, hp@immumap.com

Downloads

Download20200707_webinar_flow_cytometry.pdf

Close
What are you looking for?